# Grace Therapeutics, Inc.: Form 10-Q/A for the period ended Sep 30, 2025

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 10-Q/A
- Filed: 2025-11-17
- Accepted by EDGAR: Nov 17, 2025, 16:22 ET
- Period: 2025-09-30
- Accession: 0001140361-25-042491
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125042491/ef20059408_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036125042491/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036125042491/ef20059408_10qa.htm

Filed Nov 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-042491. Last ingested by Listed: Nov 6, 2026, 02:04 ET. No prices; not investment advice.